NEW Report Offers Few Details on How FDA Will Regulate CBD
A new report out today from the Food and Drug Administration (FDA) fails to offer a concrete plan on how the Agency will regulate CBD products. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy…
Adverse Event Reporting Tells the Story of Dietary Supplement Safety
WASHINGTON — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor…
New Illinois Copycat Legislation Would Restrict Access to Supplements and Burden Small Businesses
NPA today is calling for the Illinois state legislature to reject a proposal that would restrict consumers’ access to popular nutritional supplements and likely drive customers under the age of 18 to shop on the internet instead.
NPA Calls for Federal Approach to CBD Regulation, Urges FDA to Set a Safe Level of Daily Consumption
NPA today rejected a bill proposed in the Illinois state legislature that would prohibit the sale of CBD products that do not meet certain requirements set by the Illinois Department of Agriculture.
Natural Products Association Submits Comments for the Record to House Energy & Commerce Committee
The Natural Products Association today submitted comments to the House Energy and Commerce Committee regarding Good Manufacturing Practices (GMPs) for cosmetic products in advance of a Dec. 4, 2019 hearing entitled "Building Consumer Confidence by Empowering FDA to Improve…
Awards
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
